Fahed Al-Marzooqi - Feb 27, 2024 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTVT	Director stock option (right to buy)	Award	$47.9K	+4.06K	+162.2%	$11.81	6.56K	Feb 27, 2024	Class A Common Stock	4.06K	$11.81	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in quarterly equal installments over the three year period beginning on February 27, 2024. The option was conditioned upon shareholder approval of the 2024 Equity Incentive Plan, which was approved by the shareholders on June 11, 2024.